Martin Kleinschmidt
Fraunhofer Institute for Cell Therapy and Immunology, Germany
Biography
Martin Kleinschmidt has received his PhD in 2004 from the Martin-Luther-University Halle-Wittenberg. At the Probiodrug AG, he was responsible for biophysical characterization of interactions by SPR, ITC and X-ray structure analysis. Later he was the Project Manager for assay development. In 2013 he changed over to Fraunhofer IZI-MWT and is now Head of lab clinical and biophysical analytics. He has published 17 papers in well-known journals and is currently Associated Editor for the Journal of Alzheimer’s Disease.
Abstract
Speaker Presentations
Speaker PPTs Click Here